抗体

收藏夹比较
Alirocumab (anti-PCSK9)
- ≥95%
- 75mg/ml in buffer
关联靶标: PCSK9
CAS号 : 1245916-14-6

SMILES: C(C(COP(=O)(O)O)O)O.[Na].[Na]

InChIKey: CATWCRUATKKAAQ-UHFFFAOYSA-N

InChI: InChI=1S/C3H9O6P.2Na/c4-1-3(5)2-9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;
详情

查看价格关闭
收藏夹比较
Etrolizumab (anti-α4β7)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: ITGA4 ITGB7 ITGA7
CAS号 : 1044758-60-2
详情

查看价格关闭
收藏夹比较
Evolocumab(anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 1256937-27-5 Compound CID : 168010177

IUPAC Name: 2-butylimino-3-[1-(4-fluorophenyl)ethyl]-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;2-(cyclopropylmethylimino)-3-[1-(4-fluorophenyl)ethyl]-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;2-ethylimino-3-[1-(4-fluorophenyl)ethyl]-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;3-[1-(4-fluorophenyl)ethyl]-2-(3-hydroxypropylimino)-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazolidin-4-one;3-[1-(4-fluorophenyl)ethyl]-2-methoxy-5-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]imidazol-4-one

SMILES: CCCCN=C1NC(=CC2=CC(=C(C=C2)N3C=C(N=C3)C)OC)C(=O)N1C(C)C4=CC=C(C=C4)F.CCN=C1NC(=CC2=CC(=C(C=C2)N3C=C(N=C3)C)OC)C(=O)N1C(C)C4=CC=C(C=C4)F.CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3C(=O)N(C(=NCCCO)N3)C(C)C4=CC=C(C=C4)F)OC.CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3C(=O)N(C(=NCC4CC4)N3)C(C)C5=CC=C(C=C5)F)OC.CC1=CN(C=N1)C2=C(C=C(C=C2)C=C3C(=O)N(C(=N3)OC)C(C)C4=CC=C(C=C4)F)OC

InChIKey: PUHBRGRYFZDQIV-UHFFFAOYSA-N

InChI: InChI=1S/C27H28FN5O2.C27H30FN5O2.C26H28FN5O3.C25H26FN5O2.C24H23FN4O3/c1-17-15-32(16-30-17)24-11-6-20(13-25(24)35-3)12-23-26(34)33(27(31-23)29-14-19-4-5-19)18(2)21-7-9-22(28)10-8-21;1-5-6-13-29-27-31-23(26(34)33(27)19(3)21-8-10-22(28)11-9-21)14-20-7-12-24(25(15-20)35-4)32-16-18(2)30-17-32;1-17-15-31(16-29-17)23-10-5-19(14-24(23)35-3)13-22-25(34)32(26(30-22)28-11-4-12-33)18(2)20-6-8-21(27)9-7-20;1-5-27-25-29-21(24(32)31(25)17(3)19-7-9-20(26)10-8-19)12-18-6-11-22(23(13-18)33-4)30-14-16(2)28-15-30;1-15-13-28(14-26-15)21-10-5-17(12-22(21)31-3)11-20-23(30)29(24(27-20)32-4)16(2)18-6-8-19(25)9-7-18/h6-13,15-16,18-19H,4-5,14H2,1-3H3,(H,29,31);7-12,14-17,19H,5-6,13H2,1-4H3,(H,29,31);5-10,13-16,18,33H,4,11-12H2,1-3H3,(H,28,30);6-15,17H,5H2,1-4H3,(H,27,29);5-14,16H,1-4H3
详情

查看价格关闭
收藏夹比较
Vedolizumab (anti-α4β7-integrin)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: ITGA4 ITGB7
CAS号 : 943609-66-3 Compound CID : 168010198

IUPAC Name: 3-methylidene-7-(pyrazolo[1,5-a]pyridine-3-carbonyl)-2,7-diazaspiro[4.4]nonan-1-one

SMILES: C=C1CC2(CCN(C2)C(=O)C3=C4C=CC=CN4N=C3)C(=O)N1.C=C1CC2(CCN(C2)C(=O)C3=C4C=CC=CN4N=C3)C(=O)N1.C=C1CC2(CCN(C2)C(=O)C3=C4C=CC=CN4N=C3)C(=O)N1

InChIKey: ZMLTXCHYIRTZLL-UHFFFAOYSA-N

InChI: InChI=1S/3C16H16N4O2/c3*1-11-8-16(15(22)18-11)5-7-19(10-16)14(21)12-9-17-20-6-3-2-4-13(12)20/h3*2-4,6,9H,1,5,7-8,10H2,(H,18,22)
详情

查看价格关闭
收藏夹比较
Alirocumab (anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 1245916-14-6

SMILES: C(C(COP(=O)(O)O)O)O.[Na].[Na]

InChIKey: CATWCRUATKKAAQ-UHFFFAOYSA-N

InChI: InChI=1S/C3H9O6P.2Na/c4-1-3(5)2-9-10(6,7)8;;/h3-5H,1-2H2,(H2,6,7,8);;
详情

查看价格关闭
收藏夹比较
Tafolecimab (anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 2225109-03-3
详情

查看价格关闭
收藏夹比较
Bococizumab (anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 1407495-02-6
详情

查看价格关闭
收藏夹比较
Natalizumab (anti-ITGA4)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: ITGA4 ITGB1
CAS号 : 189261-10-7 Compound CID : 108147

IUPAC Name: (3S)-4-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxo-3-phenylpropan-2-yl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(3-carboxypropanoylamino)-4-oxobutanoic acid

SMILES: CC(C)CC(C(=O)NC(CCSC)C(=O)N)NC(=O)CNC(=O)C(CC1=CC=CC=C1)N(C)C(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(=O)O)NC(=O)CCC(=O)O

InChIKey: HMHYXLVEFVGOPM-QKUYTOGTSA-N

InChI: InChI=1S/C40H55N7O11S/c1-24(2)19-28(37(55)45-27(36(41)54)17-18-59-4)44-33(49)23-42-39(57)31(21-26-13-9-6-10-14-26)47(3)40(58)30(20-25-11-7-5-8-12-25)46-38(56)29(22-35(52)53)43-32(48)15-16-34(50)51/h5-14,24,27-31H,15-23H2,1-4H3,(H2,41,54)(H,42,57)(H,43,48)(H,44,49)(H,45,55)(H,46,56)(H,50,51)(H,52,53)/t27-,28-,29-,30-,31-/m0/s1
详情

查看价格关闭
收藏夹比较
Recombinant PCSK9 Antibody
- 1.0 mg/mL
- WB
关联靶标: PCSK9
详情

查看价格关闭
收藏夹比较
Ralpancizumab (anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 1407495-04-8
详情

查看价格关闭
收藏夹比较
Frovocimab (anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 1643672-70-1
详情

查看价格关闭
收藏夹比较
Ongericimab (anti-PCSK9)
- ≥95%(SDS-PAGE&SEC-HPLC)
- 见COA
- Animal Model
- ELISA
- Flow Cytometry
- Functional Assay
关联靶标: PCSK9
CAS号 : 2145096-91-7
详情

查看价格关闭

比较产品

删除该内容

你没有要比较的项目。

我的收藏夹

最后添加的项

你的收藏夹为空。